Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Surmises from Studying DNA Damage: A Link to Type 2 Diabetes?

This article was originally published in Start Up

Executive Summary

Researchers recently catalogued over 700 proteins associated with DNA damage and organized many of them into signaling modules. Scientists poring over this intricate data set may get insights into genetic diseases, cancer, and other complex diseases including diabetes. For example, there's a hint that long-term DNA damage affects the insulin pathway, which could revolutionize thinking about diabetes treatment by providing a set of DNA-damage-related drug targets that could stop the loss of insulin signaling and prevent the onset of the disease.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC091425

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel